vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-1483Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWПРОФИЛАКТИКА ПНЕВМОКОККОВОЙ ИНФЕКЦИИ У ДЕТЕЙ – ПОЛОЖИТЕЛЬНОЕ ВЛИЯНИЕ НА ПОПУЛЯЦИЮ В ЦЕЛОМPROPHYLAXIS OF PNEUMOCOCCAL INFECTION IN CHILDREN HAS POSITIVE EFFECT ON ALL POPULATIONФедосеенкоМ.В.FedoseenkoM.V.Научный центр здоровья детей РАМН, МоскваРоссияScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowRussian Federation20080611201576Вопросы современной педиатрии6671Copyright © Федосеенко М., 20082008Федосеенко М.Fedoseenko M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/1483ReferencesWHO Global Immunization Vision and Strategy. Доступно на: www.who.int/vaccines/GIVS/english/Global_imm._data_EN.pdf.WHO Global Immunization Vision and Strategy. Доступно на: www.who.int/vaccines/GIVS/english/Global_imm._data_EN.pdf.UNICEF. Pneumonia the forgotten killer of children. Доступно на: www.unicef.org/publications/files/Pneumonia_The_Forgotten_Killer_of_Children.pdf.UNICEF. Pneumonia the forgotten killer of children. Доступно на: www.unicef.org/publications/files/Pneumonia_The_Forgotten_Killer_of_Children.pdf.Пневмококковая инфекция респираторной системы в детском возрасте. Практическое руководство для врачей. Под ред. Н.А. Геппе, А.Б Малахова. М. 2005.Пневмококковая инфекция респираторной системы в детском возрасте. Практическое руководство для врачей. Под ред. Н.А. Геппе, А.Б Малахова. М. 2005.Катосова Л.К. Этиология пневмоний. В кн.: Острые пневмонии у детей. Под ред. В.К. Таточенко. Чебоксары: Чувашский университет. 1994.Катосова Л.К. Этиология пневмоний. В кн.: Острые пневмонии у детей. Под ред. В.К. Таточенко. Чебоксары: Чувашский университет. 1994.Weekly Epidemiological Record. 2007. №12, № 82. Р. 93–104. Доступно на: www.who.int/werWeekly Epidemiological Record. 2007. №12, № 82. Р. 93–104. Доступно на: www.who.int/werPneumococcal vaccines the impact of conjugate vaccine. Ed. by G.R. Siber, K.P. Klugman, P.H. Makela. NY: ASM Press. 2008. Р. 450.Pneumococcal vaccines the impact of conjugate vaccine. Ed. by G.R. Siber, K.P. Klugman, P.H. Makela. NY: ASM Press. 2008. Р. 450.Eskola J., Kilpi T., Palmu A. et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 2001; 344 (6): 403–409.Eskola J., Kilpi T., Palmu A. et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 2001; 344 (6): 403–409.Black S., Shinefield H., Ling S. et al Effectiveness of heptavalent-pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatrics Infect. Dis. J. 2002; 21 (9): 810–815.Black S., Shinefield H., Ling S. et al Effectiveness of heptavalent-pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatrics Infect. Dis. J. 2002; 21 (9): 810–815.Black S., Shinefield H., Fireman B. et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatrics Infect. Dis. J. 2000; 19 (3): 187–195.Black S., Shinefield H., Fireman B. et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatrics Infect. Dis. J. 2000; 19 (3): 187–195.Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease, United States, 1998-2003. MMWR. 2005; 54 (36): 893–897.Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease, United States, 1998-2003. MMWR. 2005; 54 (36): 893–897.Centers for Disease Control and Prevention. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction, 1998–2005. MMWR. 2008; 57 (6): 141–168.Centers for Disease Control and Prevention. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction, 1998–2005. MMWR. 2008; 57 (6): 141–168.Centers for Disease Control and Prevention, National Immunization Program, Record of the Advisory Committee on Immunization Practices. October 15-16 2003. Доступно на: www.cdc.gov/nip/ACIP/minutes.htmCenters for Disease Control and Prevention, National Immunization Program, Record of the Advisory Committee on Immunization Practices. October 15-16 2003. Доступно на: www.cdc.gov/nip/ACIP/minutes.htmBlack S., Shinefield H., Baxter R. et al. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatrics Infect. Dis. J. 2004; 23 (6): 485–489.Black S., Shinefield H., Baxter R. et al. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatrics Infect. Dis. J. 2004; 23 (6): 485–489.Poehling K.A., Talbot T.R., Griffin M.R. et al. Invasive pneumococcal disease among young infants before and after pneumococcal conjugate vaccine introduction. JAMA. 2006; 295 (14): 1668–1674.Poehling K.A., Talbot T.R., Griffin M.R. et al. Invasive pneumococcal disease among young infants before and after pneumococcal conjugate vaccine introduction. JAMA. 2006; 295 (14): 1668–1674.Stephens D.S., Zughaier S.M., Whitney C.G. et al. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet. 2005; 365 (9462): 855–863.Stephens D.S., Zughaier S.M., Whitney C.G. et al. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet. 2005; 365 (9462): 855–863.
The authors declare that there are no conflicts of interest present.